Humana Stock Price and Value Analysis

Should you buy Humana stock? (NYSE:HUM). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company has stable growth.
  • This company is very stable.
  • This company has a low dividend yield.
  • This stock looks overpriced.
  • This company is making money at a modest rate.

Inside the HUM Numbers

HUM Price
(Humana stock price per share)
$508.44
[?]
HUM Fair Price
(based on intrinsic value)
$106.52
[?]
HUM Safety Price (based on a variable margin of safety) $85.22
[?]
PE Ratio versus Sector 10% lower than other Healthcare stocks
[?]
PE Ratio versus Industry 37% higher than other Unknown stocks
[?]
Cash Yield 0.53%
[?]
Free Cash Flow Jitter 16%
[?]
Dividend Yield 1%
Shares Shorted 1,898,875

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,898,875 shares shorted. With 126,225,924 shares available for purchase and an average trading volume over the past 10 trading days of 990,150, it would take at least 1.918 days for all of the short holders to cover their shorts.

Is Humana Stock on Sale?

We believe that Humana may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Humana looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy HUM Stock?

Does Humana have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.